: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies.".
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..